title: Treatment for PSA screen-detected prostate cancer: what are the options?
authors.affiliation: Institute of Cancer, Department of Experimental Cancer Medicine, St Barts & The London School of Medicine, Queen Mary University of London, London, UK. r.t.oliver@qmul.ac.uk
authors.forename: R Tim D
authors.initials: RT
authors.lastname: Oliver
authors.forename: David E
authors.initials: DE
authors.lastname: Neal
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen